Literature DB >> 15334659

Dominant negative Ras enhances lactogenic hormone-induced differentiation by blocking activation of the Raf-Mek-Erk signal transduction pathway.

Maria Grazia Cerrito1, Traci Galbaugh, Weihan Wang, Treasa Chopp, David Salomon, Mary Lou Cutler.   

Abstract

Epidermal growth factor (EGF) and Ras mitogenic signal transduction pathways are frequently activated in breast carcinoma and inhibit mammary differentiation and apoptosis. HC11 mouse mammary epithelial cells, which differentiate and synthesize beta-casein following growth to confluency and stimulation with lactogenic hormones, were used to study EGF-dependent signaling during differentiation. Blocking Mek-Erk or phosphotidylinositol-3-kinase (PI-3 kinase) signaling with specific chemical inhibitors enhanced beta-casein promotor-driven luciferase activity. Because EGF stimulation of HC11 cells resulted in the activation of Ras, the effect of activated Ras (RasV12) or dominant negative (DNRasN17) on lactogen induced differentiation was examined. HC11 cell lines expressing RasV12 or DNRasN17 under the control of a tetracycline (tet)-responsive promotor were constructed. Activated RasV12 expression resulted in reduced tyrosine phosphorylation of Stat5 and a delay in beta-casein expression in response to prolactin. However, the expression of tet-regulated DNRasN17 and adenovirus-encoded DNRasN17 enhanced Stat5 tyrosine phosphorylation, Stat5 DNA binding, and beta-casein transcription. The expression of DNRasN17 blocked the activation of the Mek-Erk pathway by EGF but did not prevent the phosphorylation of AKT, a measure of activation of the PI-3-kinase pathway. Moreover, the expression of DNRasN17 prevented the block to lactogenic differentiation induced by EGF. Stimulation of HC11 cells with prolactin resulted in the association of the SHP2 phosphatase with Stat5, and this association was prevented by DNRasN17 expression. These results demonstrate that in HC11 cells DNRas inhibits the Mek-Erk pathway and enhances lactogenic hormone-induced differentiation. This occurs, in part, by inhibiting the association of the SHP2 phosphatase with Stat5. Published 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15334659      PMCID: PMC1586098          DOI: 10.1002/jcp.20077

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  51 in total

1.  Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells.

Authors:  B M Marte; M Jeschke; D Graus-Porta; D Taverna; P Hofer; B Groner; Y Yarden; N E Hynes
Journal:  Mol Endocrinol       Date:  1995-01

2.  Complex formation between RAS and RAF and other protein kinases.

Authors:  L Van Aelst; M Barr; S Marcus; A Polverino; M Wigler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

3.  Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells.

Authors:  S Cowley; H Paterson; P Kemp; C J Marshall
Journal:  Cell       Date:  1994-06-17       Impact factor: 41.582

4.  Phosphatidylinositol-3-OH kinase as a direct target of Ras.

Authors:  P Rodriguez-Viciana; P H Warne; R Dhand; B Vanhaesebroeck; I Gout; M J Fry; M D Waterfield; J Downward
Journal:  Nature       Date:  1994-08-18       Impact factor: 49.962

5.  Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro.

Authors:  P H Warne; P R Viciana; J Downward
Journal:  Nature       Date:  1993-07-22       Impact factor: 49.962

6.  Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2.

Authors:  P W Janes; R J Daly; A deFazio; R L Sutherland
Journal:  Oncogene       Date:  1994-12       Impact factor: 9.867

7.  ralGDS family members interact with the effector loop of ras p21.

Authors:  A Kikuchi; S D Demo; Z H Ye; Y W Chen; L T Williams
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

8.  Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells.

Authors:  G H Smith; R Sharp; E C Kordon; C Jhappan; G Merlino
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

Review 9.  Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.

Authors:  C J Marshall
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

10.  Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription.

Authors:  F Gouilleux; H Wakao; M Mundt; B Groner
Journal:  EMBO J       Date:  1994-09-15       Impact factor: 11.598

View more
  9 in total

1.  Prolactin receptor-integrin cross-talk mediated by SIRPα in breast cancer cells.

Authors:  Traci Galbaugh; Yvonne B Feeney; Charles V Clevenger
Journal:  Mol Cancer Res       Date:  2010-09-08       Impact factor: 5.852

2.  Connective Tissue Growth Factor (CTGF/CCN2) enhances lactogenic differentiation of mammary epithelial cells via integrin-mediated cell adhesion.

Authors:  Bethanie L Morrison; Cynthia C Jose; Mary Lou Cutler
Journal:  BMC Cell Biol       Date:  2010-05-24       Impact factor: 4.241

3.  Image-based evaluation of the molecular events underlying HC11 mammary epithelial cell differentiation.

Authors:  Liang Shan; Renshu Zhang; Wanghai Zhang; Edward Lee; Rajagopalan Sridhar; Elizabeth G Snyderwine; Paul C Wang
Journal:  Anal Biochem       Date:  2008-08-08       Impact factor: 3.365

4.  EGF-induced activation of Akt results in mTOR-dependent p70S6 kinase phosphorylation and inhibition of HC11 cell lactogenic differentiation.

Authors:  Traci Galbaugh; Maria Grazia Cerrito; Cynthia C Jose; Mary Lou Cutler
Journal:  BMC Cell Biol       Date:  2006-09-19       Impact factor: 4.241

5.  EMT-induced stemness and tumorigenicity are fueled by the EGFR/Ras pathway.

Authors:  Dominic Chih-Cheng Voon; Huajing Wang; Jason Kin Wai Koo; Juin Hsien Chai; Yit Teng Hor; Tuan Zea Tan; Yeh-Shiu Chu; Seiichi Mori; Yoshiaki Ito
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

6.  Cell type of origin as well as genetic alterations contribute to breast cancer phenotypes.

Authors:  Divya Bhagirath; Xiangshan Zhao; William W West; Fang Qiu; Hamid Band; Vimla Band
Journal:  Oncotarget       Date:  2015-04-20

7.  Global expression profiling reveals regulation of CTGF/CCN2 during lactogenic differentiation.

Authors:  Weihan Wang; Cynthia Jose; Nicholas Kenney; Bethanie Morrison; Mary Lou Cutler
Journal:  J Cell Commun Signal       Date:  2009-04-08       Impact factor: 5.782

8.  Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study.

Authors:  Maria Grazia Cerrito; Marco De Giorgi; Davide Pelizzoni; Sara Maria Bonomo; Nunzio Digiacomo; Arianna Scagliotti; Cristina Bugarin; Giuseppe Gaipa; Emanuela Grassilli; Marialuisa Lavitrano; Roberto Giovannoni; Paolo Bidoli; Marina Elena Cazzaniga
Journal:  Oncotarget       Date:  2018-06-08

Review 9.  RAS as Supporting Actor in Breast Cancer.

Authors:  Mirco Galiè
Journal:  Front Oncol       Date:  2019-11-12       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.